Lucira Health (LHDXQ) Versus Its Peers Head-To-Head Contrast
Lucira Health (LHDXQ) Versus Its Peers Head-To-Head Contrast
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 42 public companies in the "Diagnostic substances" industry, but how does it compare to its peers? We will compare Lucira Health to similar businesses based on the strength of its profitability, risk, institutional ownership, dividends, earnings, analyst recommendations and valuation.
Lucira Health（納斯達克股票代碼：LHDXQ — 獲取評級）是 “診斷物質” 行業的42家上市公司之一，但與同行相比如何？我們將根據Lucira Health的盈利能力、風險、機構所有權、股息、收益、分析師建議和估值的實力，將其與同類企業進行比較。
Earnings & Valuation
收益與估值
This table compares Lucira Health and its peers top-line revenue, earnings per share and valuation.
該表比較了Lucira Health及其同行的最高收入、每股收益和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Lucira Health | $93.06 million | -$64.83 million | -0.05 |
| Lucira Health Competitors | $466.17 million | $9.58 million | -52.37 |
| 總收入 | 淨收入 | 市盈率 | |
| 露西拉健康 | 9306 萬美元 | -6,483 萬美元 | -0.05 |
| 露西拉健康競爭對手 | 4.6617 億美元 | 958 萬美元 | -52.37 |
Lucira Health's peers have higher revenue and earnings than Lucira Health. Lucira Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Lucira Health的同行比Lucira Health的收入和收益更高。Lucira Health的市盈率高於同行，這表明它目前比該行業的其他公司更昂貴。
Volatility & Risk
波動性與風險
Lucira Health has a beta of 3.36, indicating that its share price is 236% more volatile than the S&P 500. Comparatively, Lucira Health's peers have a beta of 1.38, indicating that their average share price is 38% more volatile than the S&P 500.
Lucira Health的beta值爲3.36，這表明其股價的波動性比標準普爾500指數高236％。相比之下，Lucira Health的同行的beta值爲1.38，這表明他們的平均股價波動性比標準普爾500指數高38％。
Profitability
盈利能力
This table compares Lucira Health and its peers' net margins, return on equity and return on assets.
該表比較了Lucira Health及其同行的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| Lucira Health Competitors | -1,437.85% | -124.65% | -30.99% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
| 露西拉健康競爭對手 | -1,437.85% | -124.65% | -30.99% |
Institutional & Insider Ownership
機構和內部所有權
57.0% of Lucira Health shares are held by institutional investors. Comparatively, 45.4% of shares of all "Diagnostic substances" companies are held by institutional investors. 30.4% of Lucira Health shares are held by insiders. Comparatively, 14.1% of shares of all "Diagnostic substances" companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Lucira Health的57.0％股份由機構投資者持有。相比之下，所有 “診斷物質” 公司的45.4％的股份由機構投資者持有。Lucira Health的30.4％的股份由內部人士持有。相比之下，所有 “診斷物質” 公司的14.1％的股份由內部人士持有。強大的機構所有權表明對沖基金、大型基金經理和捐贈基金認爲股票有望實現長期增長。
Analyst Ratings
分析師評級
This is a summary of current recommendations and price targets for Lucira Health and its peers, as reported by MarketBeat.
據MarketBeat報道，這是Lucira Health及其同行當前的建議和目標價格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| Lucira Health Competitors | 341 | 626 | 1235 | 19 | 2.42 |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不適用 |
| 露西拉健康競爭對手 | 341 | 626 | 1235 | 19 | 2.42 |
As a group, "Diagnostic substances" companies have a potential upside of 37.76%. Given Lucira Health's peers higher probable upside, analysts plainly believe Lucira Health has less favorable growth aspects than its peers.
作爲一個整體，“診斷物質” 公司的潛在上漲空間爲37.76％。鑑於Lucira Health的同行可能更高的上行空間，分析師顯然認爲Lucira Health的增長方面不如同行那麼有利。
Summary
摘要
Lucira Health beats its peers on 6 of the 9 factors compared.
在比較的9個因素中，Lucira Health在6個因素上擊敗了同行。
About Lucira Health
關於 Lucira Health
(Get Rating)
（獲取評級）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家醫療技術公司。它專注於變革性和傳染病檢測試劑盒的開發和商業化。Lucira Health Inc. 總部位於加利福尼亞州的埃默裏維爾。
Receive News & Ratings for Lucira Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lucira Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Lucira Health Daily 的新聞和評級 -在下面輸入您的電子郵件地址，即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Lucira Health及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。